TCR2
TCR2 is a discovery stage pharmaceutical company focused on engineering T cells for cancer therapy. The company's vast expertise in T cell engagement and a deep understanding of T cell receptor biology enabled the creation of a novel first-in-class approach that is highly differentiated from CAR-T cells and from T cells engineered to express defined TCR alpha/beta chains. TCR2 was founded by Dr. Patrick Baeuerle and MPM Capital. It has scientific operations in Kendall Square, Cambridge, Massachusetts to leverage best-in-class technologies and nucleate top-tier academic laboratories around the world.
TCR2
Social Links:
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical Therapeutics
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tcr2.com
Total Employee:
101+
Status:
Active
Contact:
617.475.8469
Email Addresses:
[email protected]
Total Funding:
173.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Google Universal Analytics Wordpress Plugins Nginx
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Cogent Biosciences
Cogent Biosciences is a biopharmaceutical company that develops therapies for solid cancer tumors.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Haitong International Securities Group
Haitong International Securities Group investment in Series B - TCR2
6 Dimensions Capital
6 Dimensions Capital investment in Series B - TCR2
Sirona Capital
Sirona Capital investment in Series B - TCR2
ArrowMark Partners
ArrowMark Partners investment in Series B - TCR2
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - TCR2
Syno Capital
Syno Capital investment in Series B - TCR2
curative ventures
curative ventures investment in Series B - TCR2
Hillhouse Capital Group
Hillhouse Capital Group investment in Series B - TCR2
Cathay Capital
Cathay Capital investment in Series B - TCR2
F2 Ventures
F2 Ventures investment in Series B - TCR2
Official Site Inspections
http://www.tcr2.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.59 K
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago